{
    "2019-11-01": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Novartis says delayed telling FDA of Zolgensma concern due to &quot;mistake&quot;",
                "features": {
                    "keywords": [
                        "Novartis",
                        "FDA",
                        "Zolgensma",
                        "delayed",
                        "mistake"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "UPDATE 1-Novartis arthritis drug falls short in challenge to global bestseller",
                "features": {
                    "keywords": [
                        "Novartis",
                        "arthritis",
                        "drug",
                        "falls short",
                        "global bestseller"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Novartis arthritis drug fails to prove it is significantly better than rival",
                "features": {
                    "keywords": [
                        "Novartis",
                        "arthritis",
                        "drug",
                        "fails",
                        "rival"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}